HCC vs. CLD hnRNPH1 mRNA: 85.2%/76.5%, 0.865AFP: 69.3%/87.9%, 0.785hnRNPH1 + AFP: 87.5%/84.8%, 0.891HCC vs. cirrhosis hnRNPH1 mRNA: 86.4%/54.0%, 0.647AFP: 46.6%/88.3%, 0.674hnRNPH1 + AFP: 50.3%/91.0%, 0.749. This evidence concerns the gene AFP and hepatocellular carcinoma.